Letter to FDA Opposing Approval of Bedaquiline
December 21, 2012
View as PDF.
View press release.
Public Citizen strongly opposes the accelerated approval of bedaquiline because patients taking the drug, in addition to standard TB treatment, during a phase 2 clinical trial were five times likelier to die than those who took a placebo.
January 16, 2013: FDA response to our letter